https://www.selleckchem.com/pr....oducts/glesatinib.ht
05). The survival time was four to24months (mean 19.46months). Thesixmonth and oneyear survival rates were 80.95% and 52.38%, respectively. During the follow-up period, no complications occurred except for aseptic prosthesis loosening in one patient. En bloc resection and intercalary prosthesis implantation can reduce pain, improve limb function, prolong survival time, and improve quality of life in patients with humeral diaphyseal bone metastases. En bloc resection and intercalary prosthesis implantation can reduce pain, improve lim
Like
Comment
Share
